Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Pauls Dietrich John
President and CEO at DiaMedica Therapeutics. Filing since 11 Dec 2018.
CIK 0001760123
Company
Date
Role
Action
Shares
Amount
Of holding
DMAC
DiaMedica Therapeutics Inc.
23 Jun 2023
President and CEO
Bought
12,787
$50.00K
22.9%
DMAC
DiaMedica Therapeutics Inc.
16 Nov 2022
President and CEO
Bought
20,000
$24.20K
55.9%
DMAC
DiaMedica Therapeutics Inc.
16 Aug 2021
President and CEO
Bought
5,000
$15.70K
16.2%
DMAC
DiaMedica Therapeutics Inc.
16 Aug 2019
President and CEO
Bought
1,000
$2.68K
3.4%
DMAC
DiaMedica Therapeutics Inc.
11 Dec 2018
President and CEO
Bought
5,000
$20.00K
20.2%
5 decisions on file.
